ISSN: 2206-7418Nanotheranostics
- Current issue
- Volume 8; 2024
- Volume 7; 2023
- Volume 6; 2022
- Volume 5; 2021
- Volume 4; 2020
- Volume 3; 2019
- Volume 2; 2018
- Volume 1; 2017
- Archive
- Cover images
- Cover suggestion
- Index & coverage
- Special issues
International Journal of Biological Sciences
International Journal of Medical Sciences
Global reach, higher impact
Nanotheranostics 2024; 8(1):90-99. doi:10.7150/ntno.88849 This issue Cite
Review
Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer
1. Department of Neuroscience, City University of Hong Kong, Kowloon, Hong Kong SAR, China.
2. Department of Pharmacy, Jagannath University, Dhaka-1100, Bangladesh.
Abstract
Neurodegenerative disorders encompass diseases that involve the degeneration of neurons, particularly those within the central nervous system. These are the most commonly observed disorders among the geriatric population. The treatment or management of this condition presents additional challenges due to therapeutics that may not be as effective as desired. The primary obstacle that often hinders the efficacy of therapy is the existence of a blood-brain barrier (BBB). The BBB serves as a vital safeguard for the brain, effectively obstructing the passage of drugs into the brain cells. Hence, the management of damaging neurodegenerative conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), Cerebrovascular diseases (CVDs), Huntington's disease (HD), and Multiple sclerosis (MS) is currently the primary area of research interest. The innovative utilization of nanoparticles as drug carriers provides renewed optimism in addressing many complicated medical conditions. In this article, I have aimed to gather published information regarding various lipid nanoparticles that can efficiently transport medication to the brain to address neurodegenerative disorders. According to the published literature, liposomes, solid-lipid nanoparticles, nanostructured nanoparticles, microemulsions, and nanoemulsions are potential nanocarriers that can treat neurodegenerative disorders.
Keywords: nanoparticles, neurodegenerative disorders, blood-brain barrier, nanocarriers, central nervous system (CNS)
Citation styles
